169 related articles for article (PubMed ID: 35190594)
1. Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis.
Marjanovic EJ; Sharma V; Smith L; Pinder C; Moore TL; Manning JB; Dinsdale G; Berks M; Newton VL; Wilkinson S; Dickinson MR; Herrick AL; Watson REB; Murray AK
Sci Rep; 2022 Feb; 12(1):2893. PubMed ID: 35190594
[TBL] [Abstract][Full Text] [Related]
2. Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma.
Abignano G; Aydin SZ; Castillo-Gallego C; Liakouli V; Woods D; Meekings A; Wakefield RJ; McGonagle DG; Emery P; Del Galdo F
Ann Rheum Dis; 2013 Nov; 72(11):1845-51. PubMed ID: 23426041
[TBL] [Abstract][Full Text] [Related]
3. Translational optical coherence elastography for assessment of systemic sclerosis.
Liu CH; Assassi S; Theodore S; Smith C; Schill A; Singh M; Aglyamov S; Mohan C; Larin KV
J Biophotonics; 2019 Dec; 12(12):e201900236. PubMed ID: 31343837
[TBL] [Abstract][Full Text] [Related]
4. Assessing the progression of systemic sclerosis by monitoring the tissue optic axis using PS-OCT.
Adams DC; Szabari MV; Lagares D; McCrossan AF; Hariri LP; Tager AM; Suter MJ
Sci Rep; 2020 Feb; 10(1):2561. PubMed ID: 32054932
[TBL] [Abstract][Full Text] [Related]
5. Imaging of collagen deposition disorders using optical coherence tomography.
Ring HC; Mogensen M; Hussain AA; Steadman N; Banzhaf C; Themstrup L; Jemec GB
J Eur Acad Dermatol Venereol; 2015 May; 29(5):890-8. PubMed ID: 25178655
[TBL] [Abstract][Full Text] [Related]
6. High frequency ultrasonography: reliable tool to measure skin fibrosis in SSC? A systematic literature review and additional pilot study.
Vanhaecke A; Cutolo M; Heeman L; Vilela V; Deschepper E; Melsens K; Smith V
Rheumatology (Oxford); 2021 Dec; 61(1):42-52. PubMed ID: 34037710
[TBL] [Abstract][Full Text] [Related]
7. In vivo polarisation sensitive optical coherence tomography for fibrosis assessment in interstitial lung disease: a prospective, exploratory, observational study.
Vaselli M; Kalverda-Mooij K; Thunnissen E; Tanck MWT; Mets OM; van den Berk IAH; Annema JT; Bonta PI; de Boer JF
BMJ Open Respir Res; 2023 Aug; 10(1):. PubMed ID: 37553184
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography (OCT) of collagen in normal skin and skin fibrosis.
Babalola O; Mamalis A; Lev-Tov H; Jagdeo J
Arch Dermatol Res; 2014 Jan; 306(1):1-9. PubMed ID: 24113905
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography as a method for quantitative skin evaluation in systemic sclerosis.
Pires NSM; Dantas AT; Duarte ALBP; Amaral MM; Fernandes LO; Dias TJC; de Melo LSA; Gomes ASL
Ann Rheum Dis; 2018 Mar; 77(3):465-466. PubMed ID: 28137916
[No Abstract] [Full Text] [Related]
10. Rapid, noninvasive quantitation of skin disease in systemic sclerosis using optical coherence elastography.
Du Y; Liu CH; Lei L; Singh M; Li J; Hicks MJ; Larin KV; Mohan C
J Biomed Opt; 2016 Apr; 21(4):46002. PubMed ID: 27048877
[TBL] [Abstract][Full Text] [Related]
11. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
12. Applicability of shear wave elastography for the evaluation of skin strain in systemic sclerosis.
Sobolewski P; Maślińska M; Zakrzewski J; Paluch Ł; Szymańska E; Walecka I
Rheumatol Int; 2020 May; 40(5):737-745. PubMed ID: 32146490
[TBL] [Abstract][Full Text] [Related]
13. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
14. Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma).
Scheja A; Akesson A
Clin Exp Rheumatol; 1997; 15(3):283-8. PubMed ID: 9177923
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of choroidal substructure perfusion in patients affected by systemic sclerosis: an optical coherence tomography angiography study.
Ranjbar M; Rothe M; Klapa S; Lange T; Prasuhn M; Grisanti S; Riemekasten G; Humrich JY
Scand J Rheumatol; 2020 Mar; 49(2):141-145. PubMed ID: 31526060
[No Abstract] [Full Text] [Related]
16. Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan's Skin Score on Systemic Sclerosis.
Hikmat IH; Ramdhini SS; Soekersi H; Dewi S
Acta Med Indones; 2021 Jul; 53(3):254-260. PubMed ID: 34611063
[TBL] [Abstract][Full Text] [Related]
17. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
Kissin EY; Merkel PA; Lafyatis R
Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
[TBL] [Abstract][Full Text] [Related]
18. Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.
Martyanov V; Kim GJ; Hayes W; Du S; Ganguly BJ; Sy O; Lee SK; Bogatkevich GS; Schieven GL; Schiopu E; Marangoni RG; Goldin J; Whitfield ML; Varga J
PLoS One; 2017; 12(11):e0187580. PubMed ID: 29121645
[TBL] [Abstract][Full Text] [Related]
19. High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.
Li H; Furst DE; Jin H; Sun C; Wang X; Yang L; He J; Wang Y; Liu A
Arthritis Res Ther; 2018 Aug; 20(1):181. PubMed ID: 30115105
[TBL] [Abstract][Full Text] [Related]
20. Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials?
Busquets J; Del Galdo F; Kissin EY; Jimenez SA
Rheumatology (Oxford); 2010 Jun; 49(6):1069-75. PubMed ID: 20202926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
